New drug targets for type 2 diabetes and the metabolic syndrome
Top Cited Papers
- 1 December 2001
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 414 (6865) , 821-827
- https://doi.org/10.1038/414821a
Abstract
Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.Keywords
This publication has 60 references indexed in Scilit:
- Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitusExpert Opinion on Investigational Drugs, 2001
- Glucagon antagonists for the treatment of Type 2 diabetesExpert Opinion on Therapeutic Patents, 1999
- Exploding type IIThe Lancet, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans.Journal of Clinical Investigation, 1996
- Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic ratsDiabetologia, 1994
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- Synthetic peptide antagonists of glucagon.Proceedings of the National Academy of Sciences, 1987
- Glucagon Physiology and PathophysiologyNew England Journal of Medicine, 1971